Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Address

ONE EDWARDS WAY
IRVINE, CA 92614

Founded

1958

Number of Employees

19,800

Website

http://www.edwards.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s)		 $300,533 $280,052 $630,477 $763,058 $757,460 $263,295 $625,161 $512,765 $1,726,603 $875,406 $149,996 $625,891
Average Price $11.31 $24.14 $28.71 $33.10 $45.80 $59.27 $68.13 $89.07 $85.84 $76.59 $86.72 $45.18
# Shares Purchased 26,569,260 11,599,476 21,960,891 23,056,572 16,539,930 4,442,661 9,176,467 5,757,093 20,113,539 11,430,005 1,729,657 13,852,323
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date 501.2% 181.6% 136.9% 105.5% 48.5% 14.7% -0.2% -23.7% -20.8% -11.2% -21.6% 50.5%
S&P 500 Return to Date 181.9% 173.0% 168.6% 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% 31.3% 7.4% 94.0%
Excess Total Return 319.3% 8.7% -31.7% -24.3% -56.4% -78.4% -75.0% -55.3% -58.1% -42.5% -29.0% -43.5%
Quartile Rank
Percentile Rank 92% 74% 67% 70% 57% 44% 28% 28% 27% 26% 12% 71%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
MUSSALLEM MICHAEL A

Edwards Lifesciences Corp
Zoetis Inc.
RESMED INC
MEDTRONIC PLC

Orchestra BioMed Holdings, Inc.